◆英語タイトル:Maruho Co Ltd - Strategic SWOT Analysis Review
◆商品コード:SWOT20MY2565
◆発行会社(調査会社):
GlobalData
◆発行日:2020年2月
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Maruho Co Ltd – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Highlights
Maruho Co Ltd (Maruho) is a pharmaceutical company that researches, develops, produces, and distributes dermatological products. Its product portfolio includes a wide range of prescription drugs, medical devices and other skincare products. The company also offers products for the treatment of infectious diseases, ear nose throat disorders, ophthalmological diseases, musculoskeletal disorders, central nervous system (CNS) disorders, and cardiovascular, gastrointestinal and other diseases. Maruho offers prescription drugs in various forms such as creams, ointments, lotions, tablets, injections, and gels. Its cosmeceutical products include soaps, shampoos and UV sunscreen, among others. The company has manufacturing facilities in Japan, Germany and the US. Maruho is headquartered in Osaka, Japan.
Maruho Co Ltd Key Recent Developments
Nov 20,2019: Excelra announces a drug repurposing collaboration with Maruho on dermatological applications
Nov 15,2019: Maruho establishes new research base -Installation of Satellite Lab at Shonan iPark-
Jul 31,2019: Maruho and Kose establish a jointly owned company
Jul 01,2019: Maruho establishes new US subsidiary,“Maruho America”
Mar 25,2019: Biofrontera provides corporate update; conference call details
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Maruho Co Ltd – Key Facts
Maruho Co Ltd – Key Employees
Maruho Co Ltd – Major Products and Services
Maruho Co Ltd – History
Maruho Co Ltd – Company Statement
Maruho Co Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Maruho Co Ltd – Business Description
Maruho Co Ltd – SWOT Analysis
SWOT Analysis – Overview
Maruho Co Ltd – Strengths
Maruho Co Ltd – Weaknesses
Maruho Co Ltd – Opportunities
Maruho Co Ltd – Threats
Maruho Co Ltd – Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Maruho Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Maruho Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Maruho Co Ltd, Recent Deals Summary
Section 4 – Company’s Recent Developments
Nov 20, 2019: Excelra announces a drug repurposing collaboration with Maruho on dermatological applications
Nov 15, 2019: Maruho establishes new research base -Installation of Satellite Lab at Shonan iPark-
Jul 31, 2019: Maruho and Kose establish a jointly owned company
Jul 01, 2019: Maruho establishes new US subsidiary,“Maruho America”
Mar 25, 2019: Biofrontera provides corporate update; conference call details
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Maruho Co Ltd, Key Facts
Maruho Co Ltd, Key Employees
Maruho Co Ltd, Major Products and Services
Maruho Co Ltd, History
Maruho Co Ltd, Other Locations
Maruho Co Ltd, Subsidiaries
Maruho Co Ltd, Key Competitors
Maruho Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Maruho Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Maruho Co Ltd, Recent Deals Summary
List of Figures
Maruho Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Maruho Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020